Clinical Trial Update: Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of the Na-GST-1/Alhydrogel hookworm vaccine using a controlled challenge infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hookworm Infections

Drugs mentioned

• Na-GST-1/Alhydrogel Hookworm Vaccine (Na-GST-1/Alhydrogel)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hookworm Infections | Phase 2 | Status: COMPLETED | Results posted: 2025-12-05